Return to content in this issue

 

What Do We Know About Fish Allergy at the End of the Decade?

Kourani E1, Corazza F2, Michel O3, Doyen V3,4

1Pediatric department, Rafic Hariri University Hospital, Beirut, Lebanon
2Laboratory of immunology (LHUB-ULB) and Laboratory of Translational Research, Brugmann University Hospital, Université Libre de Bruxelles (ULB), Brussels, Belgium
3Immuno-Allergology Clinic, Brugmann University Hospital, Université Libre de Bruxelles (ULB), Brussels, Belgium
4Immuno-Allergology Clinic and Laboratory of Translational Research, Brugmann University Hospital, Université Libre de Bruxelles (ULB), Brussels, Belgium

J Investig Allergol Clin Immunol 2019; Vol 29(6) : 414-421
doi: 10.18176/jiaci.0381

Fish allergy is one of the most common food allergies. It is usually considered to be IgE-mediated and correlates well with diagnostic tests such as prick tests and/or determination of specific IgE. Avoidance is the recommended treatment and is generally extended to all fish species. However, new clinical presentations have been described. These include non–IgE-mediated disease, monosensitization, and new syndromes that are sometimes associated, surprisingly, with cross-reactivity. Advances in molecular allergy have provided insights into new allergens and have increased our understanding of cross-reactivity. This paper focuses on recent publications providing information for clinicians involved in the management of fish allergy.

Key words: Food allergy, Fish, Clinical aspects, Allergens, Parvalbumin, Pseudoallergy, Cross-reactivity